Skip to main content
Log in

Purine reutilization and synthesis de novo in long-term human lymphocyte cell lines deficient in adenine phosphoribosyltransferase activity

  • Published:
Somatic Cell Genetics

Abstract

Clonal lines, with either partial or total deficiency of adenine phosphoribosyltransferase (APRT) were derived from the WI-L2 long-term human lymphocyte line by selection for resistance to the adenine analogs 8-azaadenine or 2,6-diaminopurine. Resistance to 8-wazaadenine also conferred resistance to 2,6-diaminopurine and vice versa. Cells with 30–40% of wild-type APRT activity were selected by resistance to 0.01 mM 2,6-diaminopurine or 1.40 mM 8-azaadenine. The APRT in the 8-azaadinine-resistant cells exhibited a four- to sevenfold increase in the apparent Km for adenine. Activities of three other purine reutilization and interconversion enzymes in the resistant cells, including hypoxanthine phosphoribosyltransferase (HPRT), adenosine kinase, and adenosine deaminase, were within the range of wild-type activities. The doubling times of the APRT-deficient cells in purine-free medium was not different from wild-type cells. The APRT in the 8-azaadenine-resistant cells did not have an altered mobility in glycerol gradients as compared to wild-type cells. The rate of purine synthesis de novo and intracellular levels of 5-phosphoribosyl-1-pyrophosphate were unchanged in the APRT-deficient cells as compared to WI-L2. The ability of the cells to reutilize exogenous adenine, however, was severely impaired.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature cited

  1. Kelley, W. N., Levy, R. I., Rosenbloom, F. M., Henderson, J. F., and Seegmiller, J. E. (1968).J. Clin. Invest. 47:2281–2289.

    PubMed  Google Scholar 

  2. Srivastava, S. K., Villacorte, D., and Beutler, E. (1972).Transfusion 12:190–197.

    PubMed  Google Scholar 

  3. Fox, I. H., Meade, J. C., and Kelley, W. N. (1973).Am. J. Med. 55:614–620.

    PubMed  Google Scholar 

  4. Delbarre, F., Auscher, C., Amor, B., deGery, A., Cartier, P., and Hamet, M. (1974).Biomedicine 21:82–85.

    PubMed  Google Scholar 

  5. Emmerson, B. T., Gordon, R. B., and Thompson, L. (1975).Aust. N. Z. J. Med. 5:440–446.

    PubMed  Google Scholar 

  6. Emmerson, B. T., Johnson, L. A., and Gordon, R. B. (1977). InAdvances in Experimental Medicine and Biology, Vol. 76A (Series: Purine Metabolism in Man—II: Regulation of Pathways and Enzyme Defects), (eds.) Müller, M. M., Kaiser, E., and Seegmiller, J. E. (Plenum Press, New York) pp. 293–294.

    Google Scholar 

  7. Fox, I. H. (1977). InAdvances in Experimental Medicine and Biology, Vol. 76A (Series: Purine Metabolism in Man—II: Regulation of Pathways and Enzyme Defects), (eds.) Müller, M. M., Kaiser, E., and Seegmiller, J. E. (Plenum Press, New York), pp. 265–269.

    Google Scholar 

  8. Johnson, L. A., Gordon, R. B., and Emmerson, B. T. (1917).Biochem. Genet. 15:265–272.

    Google Scholar 

  9. Cartier, P., and Hamet, M. (1974).C. R. Acad. Sci. (Paris) 279:883–886.

    Google Scholar 

  10. Debray, H., Cartier, P., Temstet, A., and Cendion, J. (1976).Pediatr. Res. 10:762–766.

    PubMed  Google Scholar 

  11. Simmonds, H. A., Van Acker, K. J., Cameron, J. S., and Snedden, W. (1976).Biochem. J. 157:485–487.

    PubMed  Google Scholar 

  12. Van Acker, K. J., Simmonds, H. A., and Cameron, J. S. (1977). InAdvances in Experimental Medicine and Biology, Vol. 76A (Series: Purine Metabolism in Man—II: Regulation of Pathways and Enzyme Defects), (eds.) Müller, M. M., Kaiser, E., and Seegmiller, J. E., (Plenum Press, New York), pp. 295–302.

    Google Scholar 

  13. Van Acker, K. J., Simmonds, A., Potter, C., and Cameron, J. S. (1977).N. Engl. J. Med. 297:127–132.

    PubMed  Google Scholar 

  14. Bennett, L. L., Jr., Vail, M. H., Chumley, S., and Montgomery, J. A. (1966).Biochem. Pharmacol. 15:1719–1728.

    Google Scholar 

  15. Bennett, L. L., Jr., Vail, M. H., Allen, P. W., and Shaddix, S. C. (1973).Biochem. Pharmacol. 22:1221–1227.

    PubMed  Google Scholar 

  16. Harris, M., and Ruddle, F. H. (1961).J. Natl. Cancer Inst. 26:1405–1411.

    PubMed  Google Scholar 

  17. Lieberman, I., and Ove, P. (1960).J. Biol. Chem. 235:1765–1768.

    PubMed  Google Scholar 

  18. Blair, D. G. R., and Hall, A. D. (1965).Can. J. Biochem. 43:1857–1878.

    PubMed  Google Scholar 

  19. Atkins, J. H., and Gartler, S. M. (1965).Genetics 60:781–792.

    Google Scholar 

  20. Chasin, L. A. (1974).Cell 2:37–41.

    PubMed  Google Scholar 

  21. Jones, G. E., and Sargent, P. A. (1974).Cell 2:43–54.

    PubMed  Google Scholar 

  22. Taylor, M. W., Pip-Korn, J. H., Tokito, M. K., and Pozzatti, R. O., Jr., (1977).Somat Cell Genet 3:195–206.

    PubMed  Google Scholar 

  23. Rappaport, H., and DeMars, R. (1973).Genetics 75:335–345.

    PubMed  Google Scholar 

  24. Levy, J. A., Buell, D. N., Creech, C., Hirshaut, Y., and Silverberg, H. (1971).J. Natl. Cancer Inst. 46:647–652.

    PubMed  Google Scholar 

  25. Wood, R. W., Becker, M. A., and Seegmiller, J. E. (1973).Biochem. Genet. 9:261–274.

    PubMed  Google Scholar 

  26. Lever, J. E., Nuki, G., and Seegmiller, J. E. (1974).Proc. Natl. Acad. Sci. U.S.A. 71:2679–2683.

    PubMed  Google Scholar 

  27. Hershfield, M. S., and Seegmiller, J. E. (1976).J. Biol. Chem. 251:7348–7354.

    PubMed  Google Scholar 

  28. Hershfield, M. S., Spector, E. B., and Seegmiller, J. E. (1977). InAdvances in Experimental Medicine and Biology, Vol. 76A (Series: Purine Metabolism in Man—II: Regulation of Pathways and Enzyme Defects), (eds.) Müller, M. M., Kaiser, E., and Seegmiller, J. E., (Plenum Press, New York), pp. 303–313.

    Google Scholar 

  29. Hershfleld, M. S., and Seegmiller, J. E. (1977).J. Biol. Chem. 252:6002–6010.

    PubMed  Google Scholar 

  30. Streeter, S. A., Spector, E. B., and Bloom, A. D. (1973). InLong-Term Lymphocyte Cultures in Human Genetics (eds.) Bergsma, D., Smith, G. F., and Bloom, A. D.Birth Defects: Orig. Art. Ser. 9(1):138–154.

  31. Sato, K., Sleskinski, R. S., and Littlefield, J. W. (1972).Proc. Natl. Acad. Sci. U.S.A. 69:1244–1248.

    PubMed  Google Scholar 

  32. Aoki, Y., and Moore, G. E. (1970).Exp. Cell Res. 59:259–266.

    PubMed  Google Scholar 

  33. Henderson, J. F., Fraser, J. H., and McCoy, E. E. (1974).Clin. Biochem. 7:339–358.

    PubMed  Google Scholar 

  34. Hershfield, M. S., Snyder, F. F., and Seegmiller, J. E. (1977).Science 197:1284–1287.

    PubMed  Google Scholar 

  35. Cheng, Y.-C., and Prusoff, W. H. (1974).Anal. Biochem. 60:545–550.

    PubMed  Google Scholar 

  36. Skaper, S. D., Willis, R. C., and Seegmiller, J. E. (1976).Science 193:587–589.

    PubMed  Google Scholar 

  37. Carson, D. A., and Seegmiller, J. E. (1976).J. Clin. Invest. 57:274–282.

    PubMed  Google Scholar 

  38. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951).J. Biol. Chem. 193:265–275.

    PubMed  Google Scholar 

  39. Henderson, J. F., and Khoo, M. K. Y. (1965).J. Biol. Chem. 240:2349–2357.

    PubMed  Google Scholar 

  40. Lesch, M., and Nyhan, W. L. (1964).Am. J. Med. 36:561–570.

    PubMed  Google Scholar 

  41. Zimmerman, T. P., Gerstein, N. B., Ross, A. F., and Miech, R. P. (1971).Can. J. Biochem. 49:1050–1054.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spector, E.B., Hershfield, M.S. & Seegmiller, J.E. Purine reutilization and synthesis de novo in long-term human lymphocyte cell lines deficient in adenine phosphoribosyltransferase activity. Somat Cell Mol Genet 4, 253–264 (1978). https://doi.org/10.1007/BF01542842

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01542842

Keywords

Navigation